Eurepa 0.5 Tablet 15's
₹151.7*
MRP ₹168.5
10% off
₹143.5*
MRP ₹168.5
15% CB
₹25 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Eurepa 0.5 Tablet 15's belongs to the category of medicines called 'anti-diabetic primarily used for the management and treatment of type 2 diabetes, especially in persons whose sugar levels are too high and cannot be only controlled by dieting and exercising. Type 2 diabetes is a condition that occurs when there is either less insulin or available insulin is not properly utilized by our body cells for lowering raised blood glucose. It is the most common type of diabetes, accounting for around 90% of total diabetes cases found commonly in middle-aged people. So it is also called adult-onset diabetes or non-insulin-dependent diabetes mellitus (NIDDM).
Eurepa 0.5 Tablet 15's contains 'Repaglinide' is a meglitinide that works by increasing the amount of insulin released by the pancreas. It starts acting so quickly on controlling blood sugar levels immediately after a meal. Eurepa 0.5 Tablet 15's may be advised with or without other medications along with diet and exercise to control blood sugar levels.
Your doctor will decide what dose should be taken for better advice, and it can change timely depending upon your condition. In some cases, you may experience headache, stomach pain, a sign of a common cold, diarrhoea, joint pain and back pain. Most of these side effects of Eurepa 0.5 Tablet 15's do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
You should not take Eurepa 0.5 Tablet 15's if you have type 1 diabetes mellitus, renal impairment, metabolic acidosis, including diabetic ketoacidosis (excess acids in your blood), severe kidney, or liver disease. Please inform your doctor if you have any heart disease, are planning to get pregnant, or are breastfeeding. Eurepa 0.5 Tablet 15's should not be stopped even if you feel better, without consulting your doctor as sugar level keeps changing. If you stop taking Eurepa 0.5 Tablet 15's abruptly, it may increase your sugar levels which could further increase the risk of eyesight loss (retinopathy), kidney (nephropathy), and nerve damage (neuropathy).
Eurepa 0.5 Tablet 15's belongs to the group of medicines called “anti-diabetic” indicated in the treatment of type 2 diabetes or non-insulin-dependent diabetes (NIDDM). This medicine is primarily prescribed to persons whose blood sugar levels are high and is even not controlled by diet and exercise alone. Eurepa 0.5 Tablet 15's consists of Repaglinide belongs to a class of meglitinide that works by increasing the amount of insulin released by the pancreas. It starts acting so quickly on controlling blood sugar levels immediately after a meal. Eurepa 0.5 Tablet 15's may be advised with or without other medications along with diet and exercise to control blood sugar levels.
Eurepa 0.5 Tablet 15's should not be used in patients with type 1 diabetes or with diabetic ketoacidosis (in this condition, there is too much lactic acid accumulated in the blood). Inform your doctor if you take other antidiabetic drugs to adjust the dosage of Eurepa 0.5 Tablet 15's accordingly. Do not abruptly stop taking Eurepa 0.5 Tablet 15's midway if the doctor did not advise you. Eurepa 0.5 Tablet 15's may cause hypoglycaemia (low blood sugar), hence it is advised to make healthy food with enough calories and avoid heavy exercises. Eurepa 0.5 Tablet 15's is not recommended for use during pregnancy and breastfeeding. Your doctor may advise alternate medications to control your diabetic condition in such cases. Eurepa 0.5 Tablet 15's is not recommended for people younger than 18 years or over 75 years of age. Before you start taking Eurepa 0.5 Tablet 15's, tell your doctor if you have serious heart disease or if you have had a stroke, low blood pressure (hypotension), and severe liver or kidney disease. Avoid alcohol intake while using Eurepa 0.5 Tablet 15's since it may increase the risk of lactic acidosis.
Drug-Drug Interactions: Eurepa 0.5 Tablet 15's may interact with insulin, high blood pressure-lowering pills (amlodipine, metoprolol, atenolol, propranolol, bisoprolol, benazepril, enalapril), water pills/diuretics (hydrochlorothiazide, furosemide), heart failure-related medicines (digoxin), painkiller (aspirin), a medicine used to treat cancer (octreotide, danazol), antibiotics (clarithromycin, trimethoprim, rifampicin), antifungal (itraconazole, ketoconazole), a medicine used to treat high blood fats (gemfibrozil), a medicine used to suppress the immune system (ciclosporin) steroids (prednisolone), medicine prevents blood clots (clopidogrel), a medicine used to treat epilepsy (phenytoin, carbamazepine, phenobarbital), thyroid hormones.
Drug-Food Interactions: Taking Eurepa 0.5 Tablet 15's with St. John’s wort (herbal medicine) and alcoholic beverages may increase the risk of a rare but serious and potentially life-threatening condition known as lactic acidosis (build-up of lactic acid in the blood) hypoglycemia.
Drug-Disease Interactions: Eurepa 0.5 Tablet 15's should be avoided in patients with kidney problems, liver problems, cardiovascular disease (heart-related issues), and low blood sugar levels (hypoglycemia) may worsen the condition.
Diabetes mellitus 2, also known as adult-onset diabetes, is a metabolic disease that causes high blood sugar levels. It is type 2 diabetes and occurs when the insulin (a hormone produced by the beta cells of the pancreas) is resistant in breaking the glucose to produce energy (insulin resistance) or the pancreas (an organ behind the stomach) produce little or no insulin at all. This disease mostly occurs in people aged above 40 years, but can also occur in childhood based on the risk factors. The treatment includes oral glucose-lowering medicines and insulin shots.
Country of origin
Manufacturer/Marketer address
Customers Also Bought
Alcohol
Unsafe
You are recommended not to consume alcohol along with Eurepa 0.5 Tablet 15's to avoid unpleasant side-effects.
Pregnancy
Caution
Eurepa 0.5 Tablet 15's is pregnancy category C drug. As the data around the use of Eurepa 0.5 Tablet 15's in pregnant women is limited, the use of Eurepa 0.5 Tablet 15's in pregnancy is restricted. It is highly recommended to consult your doctor before taking this drug in case you are pregnant.
Breast Feeding
Caution
It is unknown whether Eurepa 0.5 Tablet 15's is excreted in human milk. Please consult a doctor before using Eurepa 0.5 Tablet 15's while breastfeeding.
Driving
Caution
Your driving may be affected if your blood sugar levels are too high or too low. Do not drive or operate machinery if you also experience blurred vision, dizziness or drowsiness due to extremely low or high blood sugar.
Liver
Caution
Eurepa 0.5 Tablet 15's to be taken with caution, especially if you have a history of liver diseases/conditions. The dose may have to be adjusted by your doctor. However, Eurepa 0.5 Tablet 15's is not recommended for severe liver disease.
Kidney
Caution
Eurepa 0.5 Tablet 15's to be taken with caution, especially if you have a history of Kidney diseases/conditions. The dose may have to be adjusted by your doctor. However, Eurepa 0.5 Tablet 15's is not recommended for severe kidney disease.
Children
Unsafe
The safety and efficacy of Eurepa 0.5 Tablet 15's in children have not been established. Eurepa 0.5 Tablet 15's is not recommended in children.
Product Substitutes
Recommended for a 30-day course: 4 Strips